Final answer:
During antihyperlipidemic therapy, Kristin should anticipate ongoing liver function tests to monitor liver health as the liver is crucial in drug metabolism for cholesterol treatment.
Step-by-step explanation:
During antihyperlipidemic therapy, Kristin should anticipate ongoing liver function tests (LFTs) as part of her laboratory monitoring. The liver plays a crucial role in metabolizing many drugs, including those used to treat high cholesterol levels, and therefore must be monitored for potential drug-induced hepatotoxicity. Tests such as alkaline phosphatase, alanine aminotransferase (ALT), aspartate aminotransferase (AST), and bilirubin levels are common biomarkers used to assess liver health.